Consolidated Balance Sheets - USD ($) $ in Thousands	Feb. 28, 2026	May 31, 2025
Current assets
Cash	$ 37,810	$ 55,893
Accounts receivable, net of allowances of $1,759 and $2,215 respectively	45,552	42,890
Inventories	58,578	62,006
Prepaid expenses and other	13,612	7,535
Total current assets	155,552	168,324
Property, plant and equipment, net	29,142	32,300
Intangible assets, net	65,486	69,116
Other assets	10,498	10,404
Total assets	260,678	280,144
Current liabilities
Accounts payable	29,105	33,291
Accrued liabilities	32,303	35,518
Other current liabilities	4,658	7,388
Total current liabilities	66,066	76,197
Deferred income taxes	4,554	4,073
Other long-term liabilities	16,701	16,904
Total liabilities	87,321	97,174
Commitments and contingencies (Note 14)
Stockholders' equity
Preferred stock, par value $0.01 per share, 5,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock, par value $0.01 per share, 75,000,000 shares authorized; 42,295,944 and 41,607,877 shares issued and 41,682,097 and 40,994,030 shares outstanding at February 28, 2026 and May 31, 2025, respectively	387	385
Additional paid-in capital	632,179	621,186
Accumulated deficit	(454,534)	(429,197)
Treasury stock, 613,847 shares, at cost at February 28, 2026 and May 31, 2025, respectively	(7,381)	(7,381)
Accumulated other comprehensive income (loss)	2,706	(2,023)
Total Stockholders’ Equity	173,357	182,970
Total Liabilities and Stockholders' Equity	$ 260,678	$ 280,144